Sign Up for Alerts
Sign up to receive receive industry-specific emails from our legal team.
Sign Up for Alerts
We provide tailored, industry-specific legal updates to our clients and other friends of the firm.
Areas of Interest
February 13th, 2026
California’s attorney general issues largest CCPA fine to date
The IAPP article California’s Attorney General Issues Largest CCPA Fine to Date quotes Daniel M. Goldberg on the state’s escalating privacy enforcement. Commenting on the $2.75 million settlement, Mr. Goldberg noted that the monetary penalty may be modest compared to the cost of responding to a complex investigation and bringing large, multi-service companies into compliance. He explained that regulators increasingly expect businesses to unify opt-out rights across devices and services, even though technological and organizational silos can make that difficult in practice. “Regulatory expectations do not always align neatly with technological realities,” he said. View article.
Other Quoted
Climate Diaries Cannes Lions 2026
Jeffrey A. Greenbaum is featured in the 51toCarbonZero article, Climate Diaries Cannes Lions 2026, which features eleven interviews with senior leaders from across the media and advertising industry conducted at the Cannes Lions International Festival of Creativity. Read more.
August 5 2026
‘I have been hunted down by HR reps, lawyers, and comms people:’ Developers discuss the pain and prevalence of side work clauses
Wendy Stryker was quoted in a Game Developer article discussing "side work clauses," also known as "moonlighting clauses," in video game industry employment contracts. Read more.
July 30 2026
Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads
Jeffrey A. Greenbaum was quoted in the Regulatory Affairs Professionals Society (RAPS) article, "Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads." The article discusses the FDA's proposal to eliminate the "adequate provision" requirement in direct-to-consumer (DTC) prescription drug advertising, a change that experts say could effectively result in a de facto ban on prescription drug advertisements. Read more.
July 21 2026
